NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP
Nephros, Inc. NEPH
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$18.8M
▲ 32.7% vs FY2024
EPS · FY25
$0.11
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
—
Net margin · FY25
6.4%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 18.8M
Revenue, FY2025 · full 17-year series below
Revenue
Net income
6 cents of every revenue dollar became profit this year.
Per share
USD 0.11
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
—
Return on equity, FY2025
ROE
Operating margin6.1%
Net margin6.4%
Return on assets9.6%
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+17.0% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+23.5%
+17.0%
+25.5%
+13.2%
Net income
−7.6%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.01B
Shares outstanding, FY2025
Change, 5 years+7.8%
Change, 10 years—
The share count grew 8% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 13.6M
total assets, end of FY2025
Total assetsUSD 13.6M
CashUSD 5.4M
Current ratio4.06×
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
·
Operating income $B
0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
·
EBITDA $B
0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
·
Income tax $B
0.0
0.0
0.0
0.0
0.0
·
−0.0
−0.0
−0.0
·
·
·
·
·
·
·
·
Net income $B
0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
0.0
−0.0
EPS, diluted $
0.11
0.01
−0.15
−0.73
−0.41
−0.52
−0.45
−0.50
−0.02
−0.06
−0.09
−0.31
−0.18
−0.59
−0.81
1.86
−6.32
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
·
0.9
−22.6
−82.2
−31.9
−52.6
−75.0
−118.4
−61.8
·
·
·
·
−1603.6
−899.5
370.8
−617.1
Shares out B
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.06
0.05
0.05
0.03
0.02
0.01
0.01
0.00
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
64 of 64
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed